Beam Therapeutics Inc (BEAM)
21.27
-1.27
(-5.63%)
USD |
NASDAQ |
May 10, 16:00
21.27
0.00 (0.00%)
After-Hours: 18:36
Beam Therapeutics Shareholders Equity (Quarterly): 913.49M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 913.49M |
December 31, 2023 | 981.33M |
September 30, 2023 | 778.94M |
June 30, 2023 | 811.64M |
March 31, 2023 | 761.51M |
December 31, 2022 | 733.47M |
September 30, 2022 | 714.48M |
June 30, 2022 | 800.16M |
March 31, 2022 | 829.07M |
December 31, 2021 | 826.74M |
September 30, 2021 | 853.81M |
Date | Value |
---|---|
June 30, 2021 | 548.55M |
March 31, 2021 | 422.43M |
December 31, 2020 | 245.56M |
September 30, 2020 | 200.07M |
June 30, 2020 | 230.82M |
March 31, 2020 | 261.39M |
December 31, 2019 | 100.94M |
September 30, 2019 | 126.72M |
June 30, 2019 | 143.65M |
December 31, 2018 | 134.03M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
100.94M
Minimum
Dec 2019
981.33M
Maximum
Dec 2023
564.24M
Average
723.98M
Median
Shareholders Equity (Quarterly) Benchmarks
Eli Lilly and Co | 12.81B |
Moderna Inc | 12.82B |
Editas Medicine Inc | 294.40M |
Intellia Therapeutics Inc | 1.050B |
Perspective Therapeutics Inc | 75.18M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.360B |
Total Liabilities (Quarterly) | 446.31M |
Current Ratio | 5.991 |